White Papers

Oct 27, 2017
Sponsored Content
What do ATM machines and eCOA have in common? Senior Scientific Advisor, Dr. Jill Platko, addresses this when discussing how to design an eCOA solution for senior populations.
Oct 27, 2017
Sponsored Content
Watch this on-demand webinar to learn the benefits and challenges of each modality used in clinical trials today, items to consider, and tips for successful eCOA modality selection.
Oct 27, 2017
Sponsored Content
Sandra “SAM” Sather is joined by Giga Smith from Coastal Carolina Health Care (CCHC) to discuss benchmarks from our 2017 eConsent Site Survey.
Oct 27, 2017
Sponsored Content
In this eConsent video, industry expert, Sandra "SAM" Sather, explains how the localisation process is easier to implement in an electronic informed consent (eConsent), and what study teams should consider as they design their eConsent solution.
Oct 03, 2017
Sponsored Content
By Marken
Direct-to-patient (DTP) services for clinical trials are growing in popularity due to their many benefits for patients and the pharma industry. With its flexible global network, highly trained personnel, supporting technology and extensive regulatory expertise, Marken offers efficient, compliant, cost-effective and personalised clinical trial logistic services.
Oct 01, 2017
Sponsored Content
By Rho
A protocol is the most important document in a clinical study as it is the foundation for subsequent operational, regulatory, and marketing objectives for the development program. This guide includes information on designing the study, drafting the synopsis, and minimizing the potential for amendments.
Oct 01, 2017
Sponsored Content
First-In-Human clinical trials are part of the exploratory early phase of drug development and represent a significant milestone in the clinical development of new medicines. Since only preclinical data are available to guide study design, including dose-selection, population, safety monitoring, appropriate expertise is critical to guarantee the safety of study participants as well as the quality of the data. The purpose of this article is to discuss some practical considerations for the design of FIH clinical trials, considering the current pharmaceutical and biotech drug discovery approach.
Oct 01, 2017
Sponsored Content
Backed by extensive usability research and, most importantly, the patient's voice, this new body map creates the ultimate user experience and delivers a more complete picture of symptom locations. Watch this on-demand webinar to learn key research findings and see our new body map revealed.
Oct 01, 2017
Sponsored Content
One of the most common concerns we hear is regarding the migration of existing paper instruments to an electronic platform. Where do we start? How do we ensure a smooth migration? What can we do to ensure regulatory requirements are satisfied? In this eBook, learn the necessary steps and key considerations for a successful migration.
Oct 01, 2017
Sponsored Content
Chesapeake IRB and CRF Health team up for a collaborative webinar to discuss informed consent oversight and visibility and why Top Pharma is turning to Electronic Informed Consent (eConsent) to exceed in these areas.
native1_300x100
lorem ipsum